Reactive oxygen-mediated processes are thought to contribute to the pa
thogenesis of Alzheimer's disease (AD). To investigate this hypothesis
we studied autopsy tissue from Il pairs of AD cases and control indiv
iduals matched for age, postmortem delay, and tissue storage time. The
temporal neocortex, which is severely involved by AD pathology, and t
he cerebellum, which is spared, were analyzed for tissue markers of li
pid peroxidation (LPO). The average chemiluminescence formed from bond
breakage in tissue homogenates during a 3-h incubation, without the p
resence of catalysts such as metal ions or ascorbate, was significantl
y increased in the AD temporal cortex to 130% of matched controls. Bas
al tissue content of LPO products (thiobarbituric acid reactive substa
nces-TBARs) was not different between groups. However, TBARs were sign
ificantly elevated in AD temporal cortex to 135% of control after the
incubation. In contrast, in the cerebellum there was no difference bet
ween AD and control tissue, indicating a disease-specific tissue effec
t. Because the use of oral antioxidants have received considerable att
ention in the last few years, the results seen in the testing of an AD
patient who took daily vitamin E supplements for 4 years is particula
rly interesting. The time course for CL reactivity in the temporal cor
tex was considerably delayed compared to all other samples. This obser
vation is consistent with the hypothesis that antioxidants within tiss
ue will quench ROS-mediated reactions. This study indicates that there
is increased susceptibility to ROS in the AD temporal cortex that may
contribute to the pathogenesis of the disease. Furthermore, our obser
vations suggest that oral antioxidant supplementation may be protectiv
e against LPO in the human brain. (C) 1997 Elsevier Science Inc.